Experimental Cancer Vaccine Sees Promising Trial Results

The mRNA jab is designed to prime the immune system to find and kill cancerous cells in the body.

Getty
Getty Images

According to a recent BBC article, researchers from Moderna and MSD have successfully completed a phase-IIb randomized clinical trial for a personalized cancer vaccine. The vaccine uses messenger-RNA technology, similar to the Covid-19 vaccine, and is designed to prime the immune system to attack cancer cells. In the trial of 157 patients taking Keytruda for advanced melanoma, the vaccine was found to reduce the risk of death or cancer progression by 44%. The vaccine is highly personalized, tailored to match each patient's cancer, and is very expensive to make, but it is a significant development in the field of cancer treatment.

Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO